In modern healthcare, in vitro diagnostics go far beyond simply telling a doctor whether a patient has a certain disease or not. Today, they are an integral part of decision-making along the entire continuum of a patient’s health or disease, enabling physicians to make full use of IVDs along the healthcare value chain.
IVDs have long been considered the “silent champion” of healthcare, influencing over 60% of clinical decision-making, while accounting for only about 2% of total healthcare spending.
Diagnostics allow laboratories to be the reliable partners that healthcare professionals need. It empowers doctors to make the right decisions for their patients at the right time; it allows people to have improved control over their health and wellbeing, and it gives payors and policymakers the confidence that they are investing in the right solutions for patients and the future of healthcare.
Modern diagnostics reduce costs by diminishing subsequent health problems, reducing hospitalisation and avoiding unnecessary treatment. The future of sustainable healthcare depends on diagnostics.
Roche Products Pty Limited ABN 70 000 132 865 | Roche Diagnostics Australia Pty Limited ABN 29 003 001 205 | Roche Diabetes Care Australia Pty Limited ABN 69 602 140 278. This website may contain information about products that are not registered for use in your country of residence and may not comply with applicable laws or regulations in that country. We do not take any responsibility for accessing such information in those circumstances. To report a suspected side effect or product complaint associated with the use of a Roche product, visit